SMA4, a selective activator of PKG1alpha, exhibits a basal EC50 of 29 µM, enhances phosphorylation of the PKG1 substrate VASP, and inhibits proliferation of hPASMCs. It is utilized in cardiovascular disease research [1].
Target:
PKA|||Others
* VAT and and shipping costs not included. Errors and price changes excepted
